M1-c6v1
- Generic Name
- M1-c6v1
- Drug Type
- Biotech
- Background
M1-c6v1 is a recombinant oncolytic virus.
A Study of Intravenous VRT106 for Locally Advanced or Metastatic Solid Tumors
- First Posted Date
- 2025-02-13
- Last Posted Date
- 2025-02-13
- Lead Sponsor
- Guangzhou Virotech Pharmaceutical Co., Ltd.
- Target Recruit Count
- 12
- Registration Number
- NCT06826313
A Study of Recombinant Oncolytic Virus M1(VRT106) in Patients With Solid Tumors
- First Posted Date
- 2024-04-16
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Guangzhou Virotech Pharmaceutical Co., Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT06368921
- Locations
- 🇨🇳
Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan, China
🇨🇳Affiliated Cancer Hospital of Shandong First Medical University, Jinan, Shandong, China
🇨🇳Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
A Study of Intravenous M1-c6v1 for Locally Advanced or Metastatic Solid Tumors
- First Posted Date
- 2023-09-21
- Last Posted Date
- 2025-03-13
- Lead Sponsor
- Guangzhou Virotech Pharmaceutical Co., Ltd.
- Target Recruit Count
- 12
- Registration Number
- NCT06046742
- Locations
- 🇯🇵
National Hospital Organization Shikoku Cancer Center, Matsuyama-shi, Ehime, Japan
🇯🇵National Cancer Center Hospital East, Kashiwa-shi, Chiba, Japan
🇯🇵St. Marianna University Hospital, Kawasaki-shi, Kanagawa, Japan
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath